Azacitidine in Treating Patients With Triple Negative Stage I-IV Invasive Breast Cancer That Can Be Removed By Surgery
Status: WITHDRAWN
Study type: INTERVENTIONAL
Conditions: Recurrent Breast Cancer|Stage IA Breast Cancer|Stage IB Breast Cancer|Stage II Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer|Stage IV Breast Cancer|Triple-negative Breast Cancer
Interventions: DRUG: azacitidine|OTHER: laboratory biomarker analysis|OTHER: immunohistochemistry staining method|GENETIC: polymerase chain reaction|GENETIC: western blotting|GENETIC: nucleic acid sequencing|PROCEDURE: therapeutic conventional surgery
Sponsor: University of Southern California
Collaborators: National Cancer Institute (NCI)